Study Conduct

Biosimilars legislation approved in New Jersey

Wednesday, November 11, 2015

Legislation sponsored by Assembly Democrats of the New Jersey General Assembly (Pamela Lampitt, Daniel Benson, Shavonda Sumter, Nancy Pinkin, and Herb Conaway Jr., M.D.) to make it easier for consumers to obtain more cost-effective, “generic” versions of biological medicines used to treat conditions such as rheumatoid arthritis, anemia, psoriasis and various forms of cancer has been signed into law.

[Read More]

SCRS adds Icon as global impact partner

Monday, November 9, 2015

The Society for Clinical Research Sites (SCRS), a global trade organization dedicated to representing the interests of clinical research sites, has announced a two-year relationship with Icon, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. Icon will participate as a global impact partner (GIP) and align with 31 other sponsors, CROs and service providers dedicated to promoting high-level communication and meaningful collaboration between industry stakeholders and clinical research sites globally.

[Read More]

Veeva Systems launches clinical trials study startup solution

Wednesday, November 4, 2015

Veeva Systems, a cloud-based software provider for the global life sciences industry, has launched its first fully integrated clinical trials study startup solution, Veeva Vault Study StartUp, which will enable life sciences organizations to manage both the content and the activities associated with activating sites for clinical trials. The solution will accelerate time to first patient enrollment, automate manual processes and deliver interoperability with the electronic trial master file (eTMF) for a single source of all trial-related content.

[Read More]